USANA (USNA) CCO Neidig nets 3,759 shares after RSU vesting

Rhea-AI Filing Summary

USANA Health Sciences Chief Commercial Officer Brent Neidig reported multiple stock transactions over three days in February 2026 related to vested restricted stock units (RSUs). On February 6, 2026, 2,219 RSUs were converted into common stock, with 1,102 common shares disposed of at $21.34 per share, leaving 1,117 common shares directly held after that date.

On February 7, 2026, a further 1,401 RSUs were converted into common stock, with 696 common shares disposed of at $21.34 per share, resulting in 1,822 directly held common shares. On February 8, 2026, 3,690 RSUs were converted, with 1,753 common shares disposed of at $21.34 per share and 3,759 common shares directly held afterward.

Following these transactions, Neidig directly held 3,759 shares of common stock and 36,584 RSUs. Each RSU represents a contingent right to receive one share of USANA common stock, and the RSUs vest in 25% increments on the anniversaries of February 6, 2023, February 7, 2022, and February 8, 2024, as applicable.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Neidig Brent

(Last) (First) (Middle)

3838 WEST PARKWAY BLVD.

(Street)

SALT LAKE CITY UT 84120

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
USANA HEALTH SCIENCES INC [ USNA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CHIEF COMMERCIAL OFFICER

3. Date of Earliest Transaction (Month/Day/Year)
02/06/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/06/2026		M		2,219	A	(1)	2,219	D
Common Stock	02/06/2026		F		1,102	D	$21.34	1,117	D
Common Stock	02/07/2026		M		1,401	A	(1)	2,518	D
Common Stock	02/07/2026		F		696	D	$21.34	1,822	D
Common Stock	02/08/2026		M		3,690	A	(1)	5,512	D
Common Stock	02/08/2026		F		1,753	D	$21.34	3,759	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	02/06/2026		M			2,219	(2)	(2)	Common Stock	2,219	$0	41,675	D
Restricted Stock Units	(1)	02/07/2026		M			1,401	(3)	(3)	Common Stock	1,401	$0	40,274	D
Restricted Stock Units	(1)	02/08/2026		M			3,690	(4)	(4)	Common Stock	3,690	$0	36,584	D

Explanation of Responses:

1. Each restricted stock unit represents a contingent right to receive one share of USNA common stock.

2. Restricted Stock Units vest 25% on the anniversary of February 6th, 2023.

3. Restricted Stock Units vest 25% on the anniversary of February 7th, 2022.

4. Restricted Stock Units vest 25% on the anniversary of February 8th, 2024.

Remarks:

	/s/ Joshua Foukas, Attorney-in-Fact	02/10/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did USANA (USNA) CCO Brent Neidig report?

Brent Neidig reported conversions of restricted stock units into USANA common stock on February 6, 7, and 8, 2026, plus related common stock dispositions at $21.34 per share, resulting in 3,759 directly held common shares and 36,584 remaining RSUs.

How many USANA (USNA) restricted stock units did Brent Neidig vest?

Neidig reported vesting 2,219 RSUs on February 6, 1,401 RSUs on February 7, and 3,690 RSUs on February 8, 2026. Each restricted stock unit represents a contingent right to receive one share of USANA common stock, according to the footnotes.

What is Brent Neidig’s USANA (USNA) share ownership after these Form 4 transactions?

After the reported transactions, Brent Neidig directly owned 3,759 shares of USANA common stock and 36,584 restricted stock units. These holdings reflect the net result of RSU conversions to common stock and dispositions of common shares during February 2026.

At what price were USANA (USNA) shares disposed of in Neidig’s Form 4?

The Form 4 shows common stock dispositions at a price of $21.34 per share on February 6, 7, and 8, 2026. These transactions are coded as “F,” indicating dispositions of shares at that stated per-share price in connection with the RSU events.

How do USANA (USNA) restricted stock units reported by Neidig vest?

The footnotes state that the RSUs vest in 25% increments on specific anniversaries: February 6, 2023; February 7, 2022; and February 8, 2024. Each vested restricted stock unit provides a contingent right to receive one share of USANA common stock.

What roles does Brent Neidig hold at USANA (USNA) in this Form 4?

In this Form 4, Brent Neidig is identified as an officer of USANA Health Sciences, serving as Chief Commercial Officer. The filing indicates that the reported transactions are filed by one reporting person and are held with direct ownership status.